Judge Affirms Opioid Judgment Against Major Pharmacy Chains

March 8, 2022 by Tom Ramstack
Judge Affirms Opioid Judgment Against Major Pharmacy Chains
Lynn Wencus, of Wrentham, Mass., holds a poster, with a likeness of her son Jeff, at her home, in Wrentham, Wednesday, March 2, 2022. Wencus lost her son to a heroin overdose in 2017. (AP Photo/Steven Senne)

TRUMBULL COUNTY, Ohio — An Ohio federal judge overseeing a class action lawsuit over the opioid crisis on Monday refused to overturn a jury verdict that held major pharmacy chains liable for contributing to the addictions and overdoses blamed for killing nearly half a million Americans since 1999.

The ruling means CVS, Walgreens and Walmart are potentially liable for billions of dollars in legal claims.

The pharmacies argued they complied with all laws on dispensing the drugs. The plaintiffs accused the pharmacies of failing to properly investigate dangers of opioids before giving them to their customers.

The judge ruled the jury’s verdict in favor of the plaintiffs was supported by the evidence, meaning it can stand.

The class action lawsuit was filed by officials from two counties in Ohio on behalf of their residents who suffered the ill effects of opioids. They claimed the pharmacies’ failure to protect patients from opioids created a public nuisance.

Lake and Trumbull counties are asking the judge for $1 billion each from the pharmacies to help in treatment or compensation for their residents. A separate hearing is pending to determine the amount of damages.

Equally important, the judgment is the first in the nation to hold pharmacies liable for the opioid crisis. Other cases against opioid distributors are pending in New York and Washington state.

Attorneys for the pharmacies said Lake and Trumbull counties needed to demonstrate pharmacists dispensed illegitimate prescriptions to specific patients to prove their case.

U.S. District Judge Dan Polster disagreed, saying the counties offered adequate aggregate evidence the pharmacies dispensed dangerous opioids without taking proper precautions.

“In particular, plaintiffs presented evidence of defendants’ dispensing of large quantities of highly addictive drugs in the counties while repeatedly failing to take legally required, effective measures to identify and resolve ‘red flags’ prior to dispensing, and failing to document any due diligence with respect to those red flags,” the judge’s ruling said.

Attorneys for the Lake and Trumbull counties issued a statement saying they agreed with the judge’s ruling and added, “At this point, we are solely focused on making sure the people of Lake and Trumbull counties receive the necessary resources to support recovery efforts in their communities.”

Opioids are a broad category of powerful, addictive and inexpensive painkillers that entered the market in the 1990s. They typically are sold under the names OxyContin, Percocet, Vicodin and fentanyl.

Initially hailed as a breakthrough to help pain sufferers return to normal lives, their addictive and dangerous tendencies became obvious within a few years.

In 2010, the U.S. government began a crackdown on pharmacists and doctors who over-prescribed opioids.

An unintended result was that addicted patients who no longer had access to opiates turned to heroin as a substitute. A 2017 survey of Utah heroin addicts showed 80% started with prescription drugs.

An advisory on the website for the Centers for Disease Control and Prevention says, “From 1999–2019, nearly 500,000 people died from an overdose involving any opioid, including prescription and illicit opioids. This rise in opioid overdose deaths can be outlined in three distinct waves.

  1. The first wave began with increased prescribing of opioids in the 1990s, with overdose deaths involving prescription opioids (natural and semi-synthetic opioids and methadone) increasing since at least 1993.
  2. The second wave began in 2010, with rapid increases in overdose deaths involving heroin.
  3. The third wave began in 2013, with significant increases in overdose deaths involving synthetic opioids, particularly those involving illicitly manufactured fentanyl. The market for illicitly manufactured fentanyl continues to change, and it can be found in combination with heroin, counterfeit pills, and cocaine.”

Tom can be reached at [email protected]

A+
a-
  • CVS
  • Litigation
  • Ohio
  • opioid judgment
  • Walgreens
  • In The News

    Health

    Voting

    Prescription Drugs

    April 17, 2024
    by Dan McCue
    Eli Lilly Obesity Drug Appears to Ease Sleep Apnea Symptoms in Trials

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its... Read More

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its obesity drug, Zepbound, can provide considerable relief to overweight people who have sleep apnea. Though the findings have yet to be published in a peer-reviewed medical... Read More

    Many Cancer Drugs Remain Unproven Five Years After Accelerated Approval, a Study Finds

    The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often... Read More

    The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives? In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such... Read More

    ALS Drug Will Be Pulled From US Market After Study Showed Patients Didn't Benefit

    WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it... Read More

    WASHINGTON (AP) — The maker of a drug for Lou Gehrig’s disease that recently failed in a large study said Thursday it will pull the medicine from the market, acknowledging it didn't help patients with the deadly neurological condition. Amylyx Pharmaceuticals announced it will voluntarily halt sales and... Read More

    April 3, 2024
    by Dan McCue
    FDA Approves New Antibiotic for Three Different Uses

    WASHINGTON — The Food and Drug Administration on Wednesday approved the drug Zevtera for the treatment of adults with certain... Read More

    WASHINGTON — The Food and Drug Administration on Wednesday approved the drug Zevtera for the treatment of adults with certain bloodstream infections, those with acute bacterial skin and skin structure infections, and adult and pediatric patients 3 months to less than 18 years old with community-acquired... Read More

    Biden and Harris Team Up for Health Care Event in North Carolina

    WASHINGTON (AP) — President Joe Biden and Vice President Kamala Harris will promote their health care agenda on Tuesday in... Read More

    WASHINGTON (AP) — President Joe Biden and Vice President Kamala Harris will promote their health care agenda on Tuesday in North Carolina, a battleground state that Democrats hope to flip in their favor after falling short to Donald Trump in the last two presidential elections. Fourteen... Read More

    March 13, 2024
    by Dan McCue
    FDA Believed Poised to Approve First Med for a Serious Liver Disease

    WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious... Read More

    WASHINGTON — The Food and Drug Administration appears poised to approve the first medicine developed specifically to treat the serious liver disease known as MASH later this week.  Metabolic dysfunction-associated steatohepatitis -- formerly known as nonalcoholic steatohepatitis — is often associated with obesity. In patients who... Read More

    News From The Well
    scroll top